enGene Therapeutics Inc. - 10-Q Filing

enGene Therapeutics entered into a second amended loan agreement with Hercules Capital, including tranche advances and warrants.

SEC EDGAR ·

Tickers: $ENGN

Read the full article at SEC EDGAR

More Regulatory news